Literature DB >> 9782727

[Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].

H C Gäckle1, G E Lang, K A Freissler, G K Lang.   

Abstract

UNLABELLED: The purpose of this retrospective study was to analyze the demographic characteristics of central serous chorioretinopathy (CSC).
METHODS: Findings of 100 consecutive subjects with CSC were evaluated. Clinical and fluorescein angiographic findings, demographic characteristics, and visual acuity were analyzed.
RESULTS: The age of the patients ranged from 28 to 68 years with a mean of 43 years. No significant sex differences were found concerning age and other parameters. The highest age peak was in the group of women. The male to female ratio was 5:1. Patients with chronic CSC were significantly older (P = 0.015) than patients with the other angiographic findings. Median visual acuity was 0.5. In 40% bilateral characteristics of CSC were found. Clinical and fluorescein angiographic findings showed no significant correlation with visual acuity.
CONCLUSION: The range of age distribution in CSC is wide. In older patients distinguishing CSC from age-related macular degeneration can be difficult.

Entities:  

Mesh:

Year:  1998        PMID: 9782727     DOI: 10.1007/s003470050310

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  20 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.

Authors:  H W Chung; C M Yun; J T Kim; S-W Kim; J Oh; K Huh
Journal:  Eye (Lond)       Date:  2014-08-01       Impact factor: 3.775

Review 3.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

4.  Imaging characteristics of bilateral CSCR cases:12 months follow up.

Authors:  Sumit Randhir Singh; Deepika C Parameswarappa; Supriya Arora; Dmitrii S Maltsev; Niroj Kumar Sahoo; Alexei N Kulikov; Claudio Iovino; Filippo Tatti; Ramesh Venkatesh; Nikitha Gurram Reddy; Ram Snehith Pulipaka; Enrico Peiretti; Jay Chhablani
Journal:  Eye (Lond)       Date:  2022-01-13       Impact factor: 3.775

Review 5.  [Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on central serous chorioretinopathy : Status 18 October 2021].

Authors: 
Journal:  Ophthalmologe       Date:  2021-12-14       Impact factor: 1.059

Review 6.  Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.

Authors: 
Journal:  Ophthalmologie       Date:  2022-04-06

Review 7.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

8.  Psychosomatic aspects in patients with central serous chorioretinopathy.

Authors:  C Spahn; J Wiek; T Burger; L Hansen
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

9.  Bilateral simultaneous central serous chorioretinopathy in a teenage girl with systemic arterial hypertension.

Authors:  Ahmad A Alwassia; Mehreen Adhi; Jay S Duker
Journal:  Int Ophthalmol       Date:  2012-09-16       Impact factor: 2.031

10.  Factors influencing the visual acuity of chronic central serous chorioretinopathy.

Authors:  Yun Young Kim; Christina J Flaxel
Journal:  Korean J Ophthalmol       Date:  2011-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.